Smith & Nephew (LON:SN) had its price objective trimmed by Credit Suisse Group from GBX 1,685 ($20.74) to GBX 1,675 ($20.61) in a research report report published on Thursday, Stock Target Advisor reports. The brokerage currently has a neutral rating on the stock.
SN has been the topic of a number of other research reports. Citigroup decreased their target price on shares of Smith & Nephew from GBX 1,700 ($20.92) to GBX 1,670 ($20.55) and set a neutral rating on the stock in a report on Thursday, June 18th. JPMorgan Chase & Co. decreased their target price on shares of Smith & Nephew from GBX 1,633 ($20.10) to GBX 1,553 ($19.11) and set a neutral rating on the stock in a report on Thursday. Shore Capital reissued a sell rating on shares of Smith & Nephew in a research note on Wednesday. UBS Group reissued a neutral rating on shares of Smith & Nephew in a research note on Tuesday, June 23rd. Finally, Berenberg Bank cut their price target on shares of Smith & Nephew from GBX 2,165 ($26.64) to GBX 2,150 ($26.46) and set a buy rating for the company in a research note on Friday, July 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. The company currently has an average rating of Hold and an average target price of GBX 1,782.25 ($21.93).
Smith & Nephew stock opened at GBX 1,517.50 ($18.67) on Thursday. The firm’s 50 day simple moving average is GBX 1,587.56 and its 200 day simple moving average is GBX 1,632.17. The company has a current ratio of 2.06, a quick ratio of 0.96 and a debt-to-equity ratio of 39.82. The firm has a market capitalization of $13.29 billion and a PE ratio of 22.19. Smith & Nephew has a 1-year low of GBX 14.99 ($0.18) and a 1-year high of GBX 2,023 ($24.90).
The firm also recently disclosed a dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Thursday, October 1st will be paid a $0.14 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a dividend yield of 0.68%. Smith & Nephew’s dividend payout ratio (DPR) is 43.86%.
In other Smith & Nephew news, insider Roland Diggelmann acquired 2,125 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was bought at an average price of GBX 1,510 ($18.58) per share, with a total value of £32,087.50 ($39,487.45).
Smith & Nephew Company Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Recommended Story: Trade War
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.